1. Home
  2. CNSP vs VCIG Comparison

CNSP vs VCIG Comparison

Compare CNSP & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNSP
  • VCIG
  • Stock Information
  • Founded
  • CNSP 2017
  • VCIG 2013
  • Country
  • CNSP United States
  • VCIG Malaysia
  • Employees
  • CNSP N/A
  • VCIG N/A
  • Industry
  • CNSP Biotechnology: Pharmaceutical Preparations
  • VCIG Diversified Commercial Services
  • Sector
  • CNSP Health Care
  • VCIG Consumer Discretionary
  • Exchange
  • CNSP Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • CNSP 5.4M
  • VCIG 5.8M
  • IPO Year
  • CNSP 2019
  • VCIG 2023
  • Fundamental
  • Price
  • CNSP $0.11
  • VCIG $1.58
  • Analyst Decision
  • CNSP Strong Buy
  • VCIG
  • Analyst Count
  • CNSP 1
  • VCIG 0
  • Target Price
  • CNSP $0.50
  • VCIG N/A
  • AVG Volume (30 Days)
  • CNSP 6.2M
  • VCIG 19.8M
  • Earning Date
  • CNSP 11-15-2024
  • VCIG 02-10-2025
  • Dividend Yield
  • CNSP N/A
  • VCIG 30.64%
  • EPS Growth
  • CNSP N/A
  • VCIG N/A
  • EPS
  • CNSP N/A
  • VCIG 7.82
  • Revenue
  • CNSP N/A
  • VCIG $23,548,256.00
  • Revenue This Year
  • CNSP N/A
  • VCIG N/A
  • Revenue Next Year
  • CNSP N/A
  • VCIG N/A
  • P/E Ratio
  • CNSP N/A
  • VCIG $0.21
  • Revenue Growth
  • CNSP N/A
  • VCIG 89.38
  • 52 Week Low
  • CNSP $0.10
  • VCIG $1.38
  • 52 Week High
  • CNSP $71.00
  • VCIG $115.64
  • Technical
  • Relative Strength Index (RSI)
  • CNSP 49.04
  • VCIG 38.52
  • Support Level
  • CNSP $0.10
  • VCIG $1.51
  • Resistance Level
  • CNSP $0.12
  • VCIG $2.24
  • Average True Range (ATR)
  • CNSP 0.01
  • VCIG 0.58
  • MACD
  • CNSP 0.00
  • VCIG -0.01
  • Stochastic Oscillator
  • CNSP 56.90
  • VCIG 0.51

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

Share on Social Networks: